Jennifer R Diamond Selected Research

ErbB Receptors (EGF Receptor)

2/2021	Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
7/2014	Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer R Diamond Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 12/2009
20	Triple Negative Breast Neoplasms 06/2022 - 01/2013
14	Breast Neoplasms (Breast Cancer) 06/2021 - 06/2009
6	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 02/2011
4	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 06/2010
3	Brain Neoplasms (Brain Tumor) 06/2022 - 07/2014
2	Neutropenia 01/2022 - 01/2017
2	Aneuploidy (Aneuploid) 11/2019 - 10/2018
2	Disease Progression 01/2019 - 01/2018
2	Fatigue 01/2017 - 02/2011
2	Vomiting 01/2017 - 02/2011
2	Nausea 01/2017 - 02/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Anemia 01/2022
1	Hyponatremia 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 02/2021
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2021
1	Paraneoplastic Cerebellar Degeneration 02/2021
1	Adenocarcinoma 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Body Weight (Weight, Body) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017
1	Stomatitis 01/2017

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 01/2021 - 06/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
6	ENMD 2076IBA 10/2018 - 06/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2015
5	Hormones (Hormone)IBA 02/2021 - 03/2020
4	sacituzumab govitecanIBA 06/2022 - 07/2017
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
4	CateninsIBA 11/2020 - 03/2014
3	atezolizumabIBA 01/2021 - 01/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 12/2018
3	PlatinumIBA 10/2020 - 02/2011
3	MLN 8237IBA 01/2020 - 05/2015
3	Aurora Kinase AIBA 01/2020 - 06/2010
3	Pharmaceutical PreparationsIBA 06/2015 - 02/2011
2	ErbB Receptors (EGF Receptor)IBA 02/2021 - 07/2014
2	adavosertibIBA 01/2021 - 03/2020
2	Capecitabine (Xeloda)FDA Link 01/2021 - 03/2020
2	sapanisertibIBA 01/2021 - 01/2020
2	RX-5902IBA 11/2020 - 11/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2019
2	Monoclonal AntibodiesIBA 01/2019 - 06/2015
2	Ado-Trastuzumab EmtansineIBA 01/2019 - 07/2014
2	Immunoconjugates (Immunoconjugate)IBA 07/2017 - 03/2016
2	Aurora KinasesIBA 01/2013 - 02/2011
1	taxaneIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Cyclin-Dependent Kinase 9IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	pertuzumabIBA 06/2021
1	Trastuzumab (Herceptin)FDA Link 06/2021
1	neratinibIBA 06/2021
1	human ERBB2 proteinIBA 02/2021
1	AntibodiesIBA 02/2021
1	anti-Yo autoantibodiesIBA 02/2021
1	CytokinesIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	BenzodiazepinesIBA 01/2021
1	pembrolizumabIBA 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	AntigensIBA 10/2020
1	AlbuminsIBA 10/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Chemokine CXCL10IBA 01/2019
1	navicixizumabIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Insulin (Novolin)FDA Link 12/2018
1	Insulin ReceptorIBA 12/2018
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 12/2018
1	Biological ProductsIBA 01/2018
1	ME-344IBA 10/2017
1	Topoisomerase I InhibitorsIBA 10/2017
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2017
1	PM 01183IBA 01/2017
1	CreatinineIBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Antimitotic AgentsIBA 03/2016
1	MesothelinIBA 03/2016
1	monomethyl auristatin EIBA 03/2016

Therapy/Procedure

12	Therapeutics 06/2022 - 06/2009
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
2	Adjuvant Chemotherapy 06/2022 - 01/2022
2	Immunotherapy 01/2021 - 01/2021
1	Oral Administration 01/2022
1	Neoadjuvant Therapy 01/2018
1	Intravenous Infusions 01/2017
1	Aftercare (After-Treatment) 01/2017